Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01307384 · ClinicalTrials.gov registry record

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study

A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.

Active
Registry status
165
Enrollment target
2
Study locations

NCT01307384 is a study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 165 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01307384, a study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
165 participants
Enrollment target
2
Study locations

Study Summary

This is a prospective, multi-center, non-randomized, non-controlled study designed to obtain survival and outcome data on the Continuum Metal on Polyethylene Acetabular System when used in primary total hip arthroplasty.

Interventions

  • DEVICE Continuum Metal on Polyethylene Acetabular System

Study Locations (2)

California

  • Sah Orthopaedic Associates - Fremont

Colorado

  • Denver Health Medical Center - Denver

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2011-03-29
Est. Completion 2027-12

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT01307384

The ClinicalTrials.gov registry entry for NCT01307384 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Continuum Metal on Polyethylene Acetabular System is the first listed.

NCT01307384 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Colorado.

Frequently Asked Questions

What is clinical trial NCT01307384 about?

NCT01307384 is a clinical study titled "Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study". This is a prospective, multi-center, non-randomized, non-controlled study designed to obtain survival and outcome data on the Continuum Metal on Polyethylene Acetabular System when used in primary total hip arthroplasty.

What is the current status of trial NCT01307384?

This trial is currently active not recruiting. The enrollment target is 165 participants. The study started on 2011-03-29. Estimated completion is 2027-12.

What conditions does trial NCT01307384 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Post Traumatic Arthritis, Inflammatory Arthritis.

What interventions are being tested in trial NCT01307384?

The interventions under investigation include: Continuum Metal on Polyethylene Acetabular System (DEVICE).

Who is sponsoring clinical trial NCT01307384?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01307384 being conducted?

This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.